ABCL - AbCellera Biologics Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2025-02-03    (Delayed quote data   2025-04-03)
Last
 2.09		 Change
 ⇓ -0.13   (-5.86%)		 Volume
  3,141,214
Open
 2.12		 High
 2.15		 Low
 2.07
8EMA (Daily)
 2.26		 40EMA (Daily)
 2.57		 50EMA (Daily)
 2.63		 STO (Daily)
 28.789		 MACD Hist (Daily)
 -0.035
8EMA (Weekly)
 2.496		 40EMA (Weekly)
 3.01		 50EMA (Weekly)
 3.21		 STO (Weekly)
 14.575		 MACD Hist (Weekly)
 -0.146
Company Profile
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes, and analyzes antibody responses to engineer new antibody drug candidates for its partners.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com